---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-003401"
form_type: "8-K"
ticker: "RAPH"
cik: "0001415397"
company_name: "Raphael Pharmaceutical Inc."
filed_at: "2025-01-14T23:59:59+00:00"
generated_at: "2026-05-28T01:52:35.907158+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Raphael Pharmaceuticals appoints Ajay Kumar Dhadha as Director and Chairman, replacing Shlomo Pilo

## Summary
- Board expanded by one seat; Ajay Kumar Dhadha appointed Director and Chairman effective January 8, 2025.
- Dhadha, age 79, is a diamond dealer, founder/CEO of Shanti Gems (1982) Ltd., and Israel Diamond Exchange member.
- No arrangement, transaction, or reportable relationship exists between Dhadha and the company under Item 404(a).
- Board concluded Dhadha is qualified and independent; standard indemnification agreement to be entered.

## SEC filing metadata
- accession: 0001213900-25-003401
- form_type: 8-K
- ticker: RAPH
- cik: 0001415397
- company_name: Raphael Pharmaceutical Inc.
- filed_at: 2025-01-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1415397/000121390025003401/0001213900-25-003401-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1415397/000121390025003401/ea0227340-8k_raphael.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-003401
- JSON: https://secwatch.observer/filing/0001213900-25-003401.json
- Plain text: https://secwatch.observer/filing/0001213900-25-003401.txt

## Key facts
- Executive change
  Ajay Kumar Dhadha was appointed as Director and Chairman at Raphael Pharmaceutical Inc..
  - Action: appointed
  - Role: Director and Chairman
  source text: The Board also selected Mr. Dhadha to be Chairman of the Board, replacing Mr. Shlomo Pilo in such role.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1415397/000121390025003401/0001213900-25-003401-index.htm
- Executive change
  Shlomo Pilo changed role as Chairman at Raphael Pharmaceutical Inc..
  - Action: replaced
  - Role: Chairman
  source text: The Board also selected Mr. Dhadha to be Chairman of the Board, replacing Mr. Shlomo Pilo in such role.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1415397/000121390025003401/0001213900-25-003401-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.